Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 926946, 9 pages
http://dx.doi.org/10.1155/2015/926946
Research Article

Saw Palmetto Extract Inhibits Metastasis and Antiangiogenesis through STAT3 Signal Pathway in Glioma Cell

1Department of Nephrology, The Fourth Affiliated Hospital of China Medical University, Shenyang, China
2Department of Emergency Medicine, The Fourth Affiliated Hospital of China Medical University, Shenyang, China
3Department of Neurology, The Fourth Affiliated Hospital of China Medical University, Shenyang, China

Received 20 August 2015; Accepted 28 October 2015

Academic Editor: Giuseppe Morgia

Copyright © 2015 Hong Ding et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. S. Surawicz, B. J. McCarthy, V. Kupelian, P. J. Jukich, J. M. Bruner, and F. G. Davis, “Descriptive epidemiology of primary brain and CNS tumors: results from the central brain tumor registry of thee United States, 1990–1994,” Neuro-Oncology, vol. 1, no. 1, pp. 14–25, 1999. View at Google Scholar · View at Scopus
  2. H. Ohgaki and P. Kleihues, “Epidemiology and etiology of gliomas,” Acta Neuropathologica, vol. 109, no. 1, pp. 93–108, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Y. Wen and S. Kesari, “Malignant gliomas in adults,” The New England Journal of Medicine, vol. 359, no. 5, pp. 492–507, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. R. C. Curry, S. Dahiya, V. Alva Venur, J. J. Raizer, and M. S. Ahluwalia, “Bevacizumab in high-grade gliomas: past, present, and future,” Expert Review of Anticancer Therapy, vol. 15, no. 4, pp. 387–397, 2015. View at Publisher · View at Google Scholar
  5. Z. G. Ouédraogo, M. Müller-Barthélémy, J. Kemeny et al., “STAT3 serine 727 phosphorylation: a relevant target to radiosensitize human glioblastoma,” Brain Pathology, 2015. View at Publisher · View at Google Scholar
  6. X. Feng, J. Wu, X. Xu et al., “A preliminary study about the interaction between basic fibroblast growth factor and signal transducer and activator of transcription 3 in glioma apoptosis,” Zhonghua Wai Ke Za Zhi, vol. 52, no. 12, pp. 939–944, 2014. View at Google Scholar
  7. L.-Y. Kong, J. Wei, A. S. Haider et al., “Therapeutic targets in subependymoma,” Journal of Neuroimmunology, vol. 277, no. 1-2, pp. 168–175, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Fugh-Berman, “Bust enhancing herbal products,” Obstetrics and Gynecology, vol. 101, no. 6, pp. 1345–1349, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Zhou, Y. Yang, H. Zhang et al., “Serenoa repens induces growth arrest, apoptosis and inactivation of STAT3 signaling in human glioma cells,” Technology in Cancer Research & Treatment, 2014. View at Publisher · View at Google Scholar
  10. Z. S. Smirnova, K. V. Ermakova, I. Y. Kubasova et al., “Experimental study of combined therapy for malignant glioma,” Bulletin of Experimental Biology and Medicine, vol. 156, no. 4, pp. 480–482, 2014. View at Publisher · View at Google Scholar
  11. M. Nagane, “Anti-angiogenic therapy for malignant glioma,” Gan To Kagaku Ryoho, vol. 41, no. 1, pp. 141–147, 2014. View at Google Scholar · View at Scopus
  12. A. K. Taraphdar, M. Roy, and R. K. Bhattacharya, “Natural products as inducers of apoptosis: implication for cancer therapy and prevention,” Current Science, vol. 80, no. 11, pp. 1387–1396, 2001. View at Google Scholar · View at Scopus
  13. E. Petrangeli, L. Lenti, B. Buchetti et al., “Lipido-sterolic extract of Serenoa repens (LSESr, Permixon) treatment affects human prostate cancer cell membrane organization,” Journal of Cellular Physiology, vol. 219, no. 1, pp. 69–76, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Jhaveri, T. C. Chen, and F. M. Hofman, “Tumor vasculature and glioma stem cells: contributions to glioma progression,” Cancer Letters, vol. 14, no. 3, pp. 783–786, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. A. L. Cohen and H. Colman, “Glioma biology and molecular markers,” Cancer Treatment and Research, vol. 163, no. 1, pp. 15–30, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Chen, Z.-X. Lin, G.-S. Lin et al., “Classification of microvascular patterns via cluster analysis reveals their prognostic significance in glioblastoma,” Human Pathology, vol. 46, no. 1, pp. 120–128, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Wang, S. Guan, G. Zhao, P. Shi, and J. Wang, “Expressions of aquaporin-4, matrix metallo-proteinase-2 and matrix metallo-proteinase-14 in peritumor edematous zone of glioma and clinical implications,” Zhonghua Yi Xue Za Zhi, vol. 94, no. 29, pp. 2290–2292, 2014. View at Google Scholar
  18. J. Zou, L. Xu, Y. Ju, P. Zhang, Y. Wang, and B. Zhang, “Cholesterol depletion induces ANTXR2-dependent activation of MMP-2 via ERK1/2 phosphorylation in neuroglioma U251 cell,” Biochemical and Biophysical Research Communications, vol. 452, no. 1, pp. 186–190, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Hamasuna, H. Kataoka, T. Moriyama, H. Itoh, M. Seiki, and M. Koono, “Regulation of matrix metalloproteinase-2 (MMP-2) by hepatocyte growth factor/scatter factor (HGF/SF) in human glioma cells: HGF/SF enhances MMP-2 expression and activation accompanying up-regulation of membrane type-1 MMP,” International Journal of Cancer, vol. 82, no. 2, pp. 274–281, 1999. View at Google Scholar · View at Scopus
  20. K. Majchrzak, W. Kaspera, J. Szymaś, B. Bobek-Billewicz, A. Hebda, and H. Majchrzak, “Markers of angiogenesis (CD31, CD34, rCBV) and their prognostic value in low-grade gliomas,” Neurologia i Neurochirurgia Polska, vol. 47, no. 4, pp. 325–331, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. H. S. Kim, A. Li, S. Ahn, H. Song, and W. Zhang, “Inositol polyphosphate-5-phosphatase F (INPP5F) inhibits STAT3 activity and suppresses gliomas tumorigenicity,” Scientific Reports, vol. 4, article 7330, 2014. View at Publisher · View at Google Scholar
  22. X.-F. Wang, G.-S. Lin, Z.-X. Lin et al., “Association of pSTAT3-VEGF signaling pathway with peritumoral edema in newly diagnosed glioblastoma: an immunohistochemical study,” International Journal of Clinical and Experimental Pathology, vol. 7, no. 9, pp. 6133–6140, 2014. View at Google Scholar · View at Scopus
  23. G. K. Gray, B. C. McFarland, S. E. Nozell, and E. N. Benveniste, “NF-κB and STAT3 in glioblastoma: therapeutic targets coming of age,” Expert Review of Neurotherapeutics, vol. 14, no. 11, pp. 1293–1306, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. Q. Zheng, L. Han, Y. Dong et al., “JAK2/STAT3 targeted therapy suppresses tumor invasion via disruption of the EGFRvIII/JAK2/STAT3 axis and associated focal adhesion in EGFRvIII-expressing glioblastoma,” Neuro-Oncology, vol. 16, no. 9, pp. 1229–1243, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. X. Xuan, S. Li, X. Lou et al., “Stat3 promotes invasion of esophageal squamous cell carcinoma through up-regulation of MMP2,” Molecular Biology Reports, vol. 42, no. 5, pp. 907–915, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Artaş and H. I. Özercan, “The expression of STAT3, BCL-XL and MMP-2 proteins in colon adenocarcinomas and their relationship with prognostic factors,” Turk Patoloji Dergisi, vol. 30, no. 3, pp. 178–183, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. S. O. Rahaman, M. A. Vogelbaum, and S. J. Haque, “Aberrant Stat3 signaling by interleukin-4 in malignant glioma cells: involvement of IL-13Rα2,” Cancer Research, vol. 65, no. 7, pp. 2956–2963, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. S. L. Fossey, A. T. Liao, J. K. McCleese et al., “Characterization of STAT3 activation and expression in canine and human osteosarcoma,” BMC Cancer, vol. 9, article 81, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Qin, C. Wang, X. Chen et al., “Dopamine induces growth inhibition and vascular normalization through reprogramming M2-polarized macrophages in rat C6 glioma,” Toxicology and Applied Pharmacology, vol. 286, no. 2, pp. 112–123, 2015. View at Publisher · View at Google Scholar
  30. Y. W. Ryu, S. W. Lim, J. H. Kim, S. H. Ahn, and J. D. Choi, “Comparison of tamsulosin plus serenoa repens with tamsulosin in the treatment of benign prostatic hyperplasia in Korean men: 1-year randomized open label study,” Urologia Internationalis, vol. 94, no. 2, pp. 187–93, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. V. Wessagowit, C. Tangjaturonrusamee, T. Kootiratrakarn et al., “Treatment of male androgenetic alopecia with topical products containing Serenoa repens extract,” Australasian Journal of Dermatology, 2015. View at Publisher · View at Google Scholar
  32. P. Morabito, M. Miroddi, S. Giovinazzo, E. Spina, and G. Calapai, “Serenoa repens as an endocrine disruptor in a 10-year-old young girl: a new case report,” Pharmacology, vol. 96, no. 1-2, pp. 41–43, 2015. View at Publisher · View at Google Scholar